https://www.fda.gov/animal-veterinary/animal-drug-compounding/inspections-recalls-and-other-actions-respect-firms-engage-animal-drug-compounding
Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Tuesday, November 26, 2024
- VITAFER-L Gold 10ml may be harmful due to hidden drug ingredient
- VITAFER-L Gold 20ml may be harmful due to hidden drug ingredient
- VITAFER-L Gold 500ml may be harmful due to hidden drug ingredient
- PeakMax may be harmful due to hidden drug ingredients
- VitalityXtra may be harmful due to hidden drug ingredient
- ZapMax may be harmful due to hidden drug ingredients
- ZoomMax may be harmful due to hidden drug ingredients
FDA Approves First Generic Propofol Injectable Emulsion for Dogs
Today the U.S. Food and Drug Administration approved PropofolVet Multidose, the first generic propofol injectable emulsion for dogs. PropofolVet Multidose is approved for use as an injectable anesthetic in dogs.
PropofolVet Multidose contains the same active ingredient (propofol injectable emulsion) as the approved brand name drug product, PropoFlo 28, which was first approved on February 4, 2011. In addition, the FDA determined that PropofolVet Multidose contains no inactive ingredients that may significantly affect the bioavailability of the active ingredient.
The country’s largest PBMs—Express Scripts, Caremark and Optum Rx—are going on offense against the FTC, arguing in a new lawsuit that the agency's recent actions and administrative process subvert the Constitution, as Noah Tong reports.
Friday, November 22, 2024
PBMs strike back at FTC, claim administrative process is unconstitutional
By Noah Tong